JACLYN HEY: Open Payments
NPI 1700214608 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,196 in 59 payments from 15 companies in 2025. Trend: 2023 $1,307 · 2024 $1,385 · 2025 $1,196
Food & beverage: $1,095Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $214 |
| GENZYME CORPORATION | 11 | $199 |
| Regeneron Healthcare Solutions, Inc. | 6 | $192 |
| GlaxoSmithKline, LLC. | 9 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $94 |
| Amgen Inc. | 4 | $85 |
| CSL Behring | 3 | $57 |
| PFIZER INC. | 2 | $38 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $29 |
Products named: DUPIXENT, NUCALA, BREZTRI, FASENRA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Hizentra, TEZSPIRE, Rhapsido.
Industry payments across MO — which companies pay providers there.
